India to United States: Exemestane Export Trade Route
India has recorded 66 verified shipments of Exemestane exported to United States, representing a combined trade value of $4.6M USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $70.3K USD. The leading Indian exporter is EUGIA PHARMA SPECIALITIES LIMITED, which accounts for 48% of total export value with 27 shipments worth $2.2M USD. On the buying side, AUROBINDO PHARMA USA., INC, is the largest importer in United States with $709.8K USD in purchases. The top 3 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, MSN LABORATORIES PRIVATE LIMITED, ZYDUS LIFESCIENCES LIMITED — together control 80% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Exemestane corridor is one of India's established pharmaceutical export routes, with 66 shipments documented worth a combined $4.6M USD. The route is dominated by EUGIA PHARMA SPECIALITIES LIMITED, which alone accounts for roughly 48% of all export value, reflecting the consolidated nature of India's exemestane manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $70.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with exemestane's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 11.1%, placing it at rank #3 among India's top exemestane export destinations globally.
On the import side, key buyers of Indian exemestane in United States include AUROBINDO PHARMA USA., INC,, XXDUSXXHARXXCEUXXCALXXUSAXXNC, AUROBINDO PHARMA USA INC and 12 others. AUROBINDO PHARMA USA., INC, is the single largest importer with 9 shipments valued at $709.8K USD.
Route Characteristics
- Average transit16 days
- Peak seasonQ1
- Primary modeSea freight
- Top portHYDERABAD AIR
Market Position
- Global rank#3
- Annual growth+11.1%
- Demand growth+11.8%
- Regulatory ease76/100
Top 10 Indian Exemestane Exporters to United States
Showing top 10 of 7 Indian suppliers exporting Exemestane to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EUGIA PHARMA SPECIALITIES LIMITED Avg $82.8K per shipment | 27 | $2.2M | 48.2% |
| 2 | MSN LABORATORIES PRIVATE LIMITED Avg $45.5K per shipment | 20 | $910.1K | 19.6% |
| 3 | ZYDUS LIFESCIENCES LIMITED Avg $97.0K per shipment | 6 | $582.2K | 12.6% |
| 4 | CIPLA LIMITED Avg $66.8K per shipment | 7 | $467.8K | 10.1% |
| 5 | CADILA HEALTHCARE LIMITED Avg $93.0K per shipment | 4 | $372.1K | 8.0% |
| 6 | CADILA HEALTHCARE LTD Avg $71.2K per shipment | 1 | $71.2K | 1.5% |
| 7 | KOIT BIOPHARMA PRIVATE LIMITED Avg $151 per shipment | 1 | $151 | 0.0% |
This table shows the top 10 of 7 Indian companies exporting exemestane to United States, ranked by total trade value. The listed exporters are: EUGIA PHARMA SPECIALITIES LIMITED, MSN LABORATORIES PRIVATE LIMITED, ZYDUS LIFESCIENCES LIMITED, CIPLA LIMITED, CADILA HEALTHCARE LIMITED, CADILA HEALTHCARE LTD, KOIT BIOPHARMA PRIVATE LIMITED. EUGIA PHARMA SPECIALITIES LIMITED is the dominant supplier with 27 shipments worth $2.2M USD, giving it a 48% market share. The top 3 suppliers together account for 80% of the total trade value on this route.
Top 10 Exemestane Importers in United States
Showing top 10 of 15 known buyers in United States receiving Exemestane shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian exemestane in United States include AUROBINDO PHARMA USA., INC,, XXDUSXXHARXXCEUXXCALXXUSAXXNC, AUROBINDO PHARMA USA INC, CARDINAL HEALTH, ZYDUS PHARMACEUTICALS USA INC, among 15 total buyers. The largest importer is AUROBINDO PHARMA USA., INC,, accounting for $709.8K USD across 9 shipments — representing 15% of all exemestane imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AUROBINDO PHARMA USA., INC, | 9 | $709.8K | 15.3% |
| 2 | XXDUSXXHARXXCEUXXCALXXUSAXXNC | 6 | $582.2K | 12.6% |
| 3 | AUROBINDO PHARMA USA INC | 3 | $524.4K | 11.3% |
| 4 | CARDINAL HEALTH | 6 | $498.0K | 10.7% |
| 5 | ZYDUS PHARMACEUTICALS USA INC | 5 | $443.3K | 9.6% |
| 6 | AUROBINDO PHARMA USA., INC | 3 | $428.6K | 9.2% |
| 7 | CIPLA USA INC UPS SUPPLY CHAIN SOLU | 6 | $373.4K | 8.0% |
| 8 | AUROLOGISTICS LLC, (AUROBINDO PHARM | 9 | $255.5K | 5.5% |
| 9 | AUROLOGISTICS LLC AUROBINDO PHARM | 1 | $178.2K | 3.8% |
| 10 | CARDINAL HEALTTH | 9 | $177.8K | 3.8% |
Showing top 10 of 15 Exemestane importers in United States on this route.
Top 10 Exemestane Formulations Imported by United States
Showing top 10 of 36 product formulations shipped on the India to United States Exemestane route, ranked by trade value
United States imports a wide range of exemestane formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — EXEMESTANE TABLETS 25 MG - 1 X 30. — accounts for $1.0M USD across 11 shipments. There are 36 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EXEMESTANE TABLETS 25 MG - 1 X 30. | 11 | $1.0M | 22.1% |
| 2 | EXEMESTANE TABLETS 25 MG (EXEMESTANE TABLETS 25MG - US) (30 S PACK) (QTY: 77085PACKS) | 1 | $350.6K | 7.6% |
| 3 | EXEMESTANE TABLETS 25 MG (EXEMESTANE TABLETS 25MG - US) (30 S PACK) (QTY: 77756PACKS) | 1 | $285.5K | 6.2% |
| 4 | EXEMESTANE TABLETS 25 MG (EXEMESTANE TAB | 1 | $246.9K | 5.3% |
| 5 | EXEMESTANE 25MG 90S COUNT MEDIKL NDC NO51991-005-90 | 3 | $244.0K | 5.3% |
| 6 | EXEMESTANE TABLETS 25 MG (EXEMESTANE TABLETS 25MG - US) (30 S PACK) (QTY: 58018PACKS) | 3 | $197.9K | 4.3% |
| 7 | EXEMESTANE TABLETS 25 MG 38842X30'S | 1 | $178.2K | 3.8% |
| 8 | EXEMESTANE TABLETS 25 MG (44092X30'S) | 3 | $143.3K | 3.1% |
| 9 | EXEMESTANE TABLETS 25MG (38927x30's PACK) | 1 | $138.5K | 3.0% |
| 10 | EXEMESTANE 25MG TABLETS NDC NO. 69097-316-02 ANDA NO. 210323 INV.QTY.19200PACK 1X30S=576000 NOS | 1 | $133.7K | 2.9% |
Showing top 10 of 36 Exemestane formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 74%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD AIR handles the highest volume with 27 shipments. Transit time averages 16 days by sea.
Market Dynamics
India's exemestane exports to United States are driven primarily by a handful of large-scale manufacturers. EUGIA PHARMA SPECIALITIES LIMITED with 27 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, MSN LABORATORIES PRIVATE LIMITED, ZYDUS LIFESCIENCES LIMITED — together account for 80% of total trade value on this route. The average shipment value of $70.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as exemestane tablets 25 mg (exemestane tablets 25mg - us) (30 s pack) (qty: 77085packs) and exemestane tablets 25 mg (exemestane tablets 25mg - us) (30 s pack) (qty: 77756packs), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, AUROBINDO PHARMA USA., INC, is the largest importer with 9 shipments worth $709.8K USD — representing 15% of all exemestane imports from India on this route. A total of 15 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $4.6M
- Avg. Shipment
- $70.3K
- Suppliers
- 7
- Buyers
- 15
- Transit (Sea)
- ~16 days
- Annual Growth
- +11.1%
Related Analysis
Reverse Direction
United States → India — Exemestane (Import)Other Exemestane Routes
Unlock the Full India to United States Exemestane Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 66 shipments on this route.
Frequently Asked Questions — India to United States Exemestane Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Exemestane to United States?
The leading Indian exporters of Exemestane to United States are EUGIA PHARMA SPECIALITIES LIMITED, MSN LABORATORIES PRIVATE LIMITED, ZYDUS LIFESCIENCES LIMITED. EUGIA PHARMA SPECIALITIES LIMITED holds the largest market share at approximately 48% of total trade value on this route.
Q What is the total value of Exemestane exports from India to United States?
India exports Exemestane to United States worth approximately $4.6M USD across 66 recorded shipments. The average value per shipment is $70.3K USD.
Q Which ports does India use to ship Exemestane to United States?
The most active port of origin is HYDERABAD AIR with 27 shipments. Indian exporters primarily use sea freight for this route, with 74% of shipments going by sea and 22% by air.
Q How long does shipping take from India to United States for Exemestane?
The average transit time for Exemestane shipments from India to United States is approximately 16 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to United States Exemestane trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 11.1% with demand growth tracking at 11.8%. The route is ranked #3 among India's top Exemestane export destinations globally.
Q How many suppliers are active on the India to United States Exemestane route?
There are currently 7 active Indian suppliers exporting Exemestane to United States. The market is moderately concentrated with EUGIA PHARMA SPECIALITIES LIMITED accounting for 48% of total shipment value.
Q Who are the main importers of Exemestane from India in United States?
The leading importers of Indian Exemestane in United States include AUROBINDO PHARMA USA., INC,, XXDUSXXHARXXCEUXXCALXXUSAXXNC, AUROBINDO PHARMA USA INC, CARDINAL HEALTH, ZYDUS PHARMACEUTICALS USA INC. AUROBINDO PHARMA USA., INC, is the largest buyer with 9 shipments worth $709.8K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Exemestane.
- 2.Supplier/Buyer Matching: 7 Indian exporters and 15 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 66 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
66 Verified Shipments
7 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists